Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia.
暂无分享,去创建一个
Hiroyuki Honda | Yuji Watanabe | H. Honda | Takeshi Kobayashi | A. Ito | H. Kikkawa | Yuji Watanabe | Atsushi Horiuchi | Takeshi Kobayashi | Akira Ito | Atsushi Horiuchi | Yuko Kuga | Hiroyuki Kikkawa | Y. Kuga
[1] H. Honda,et al. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes , 2003, Melanoma research.
[2] J. Zee,et al. Heating the patient: a promising approach? , 2002 .
[3] P. Moroz,et al. Magnetically mediated hyperthermia: current status and future directions , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[4] H. Honda,et al. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia , 2001, Cancer Immunology, Immunotherapy.
[5] Jun Yoshida,et al. Targeting Hyperthermia for Renal Cell Carcinoma Using Human MN Antigenspecific Magnetoliposomes , 2001, Japanese journal of cancer research : Gann.
[6] Takeshi Kobayashi,et al. Interstitial Hyperthermia Using Magnetite Cationic Liposomes Inhibit to Tumor Growth of VX-7 Transplanted Tumor in Rabbit Tongue , 2001 .
[7] P. Dennis,et al. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. , 2001, Cancer research.
[8] S. Kasaoka,et al. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. , 2000, International journal of oncology.
[9] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[10] M. Sliwkowski,et al. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers , 1999, Oncogene.
[11] Jun Yoshida,et al. Intracellular Hyperthermia for Cancer Using Magnetite Cationic Liposomes: Ex vivo Study , 1996, Japanese journal of cancer research : Gann.
[12] H Honda,et al. Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles. , 1996, Noshuyo byori = Brain tumor pathology.
[13] John W. Park,et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Taupitz,et al. Contrast‐enhanced MR imaging of liver and spleen: First experience in humans with a new superparamagnetic iron oxide , 1994, Journal of magnetic resonance imaging : JMRI.
[15] Takeshi Kobayashi,et al. Heat Properties of Magnetoliposomes for Local Hyperthermia , 1994 .
[16] P. Carter,et al. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies , 1993, Cancer Immunology, Immunotherapy.
[17] L. Presta,et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Toy,et al. A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. , 1991, Cancer research.
[19] C. Cordon-Cardo,et al. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.
[20] A. Ullrich,et al. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor , 1989, Molecular and cellular biology.
[21] R Weissleder,et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.
[22] C. Owen,et al. Magnetic labeling and cell sorting. , 1984, Journal of immunological methods.
[23] E. Kano,et al. Effects of Hyperthermia at 50°C on V-79 Cells in vitro , 1982 .
[24] F. Valeriote,et al. Synergistic interaction of anticancer agents: a cellular perspective. , 1975, Cancer chemotherapy reports.
[25] F. Hamdy,et al. The ne w e ngl and j our na l of medicine , 2023 .
[26] J. Baselga,et al. The epidermal growth factor receptor as a target for therapy in breast carcinoma , 2004, Breast Cancer Research and Treatment.
[27] Jun Yoshida,et al. Preparation of Tumor-Specific Magnetoliposomes and Their Application for Hyperthermia , 2001 .